Dr. Barth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8726 Old US Highway 42
Florence, KY 41042Phone+1 859-384-2660Fax+1 859-384-5248
Education & Training
University of Louisville School of MedicineClass of 2002
Certifications & Licensure
KY State Medical License 2004 - 2025- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Publications & Presentations
PubMed
- 125 citationsTargeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG MiceYaya Chu, Jessica Hochberg, Ashlin Yahr, Janet Ayello, Matthew J. Barth
Cancer Immunology Research. 2015-04-01 - 34 citationsEntinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.Sarah Frys, Zachary Simons, Matthew J. Barth, Juan J Gu, Cory Mavis
British Journal of Haematology. 2015-05-01 - 96 citationsRituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: A Children’s Oncology Group...Stanton Goldman, Lynette M. Smith, Paul J. Galardy, Sherrie L. Perkins, John Kimble Frazer
British Journal of Haematology. 2014-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
